GBM91 GBM Model
Patient-derived xenograft GBM91 is a groundbreaking tool revolutionizing Brain Cancer drug development. It enables personalized testing of potential therapies, a game-changer in treatment strategies. GBM91 PDX meticulously replicates patient tumor responses, allowing researchers to predict treatment outcomes and potential toxicity accurately. By tailoring therapies to individual patient needs, GBM91 PDX paves the way for safer and more effective Brain Cancer treatments, marking a significant advancement in preclinical drug discovery.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM91
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM91 Survival
Survival of orthotopic intracranial implanted GBM91 in Nu/Nu mice (n=5)
